SLC7A11 and Alzheimer disease: In conclusion, we demonstrate iron dyshomeostasis, upregulated xCT (perturbed glutathione metabolism) and lipid peroxidation, signatures of ferroptosis in AD, thus supporting the use of anti-ferroptotic therapies in AD.